Project Grant K99DA060979
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$174K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This National Institutes of Health National Institute on Drug Abuse Project Grant award of $234,364.35 supports research from March 1, 2021 through August 31, 2022 at clinical practices of the University of Pennsylvania located in Pennsylvania. The research aims to characterize a nociception-active basolateral amygdala to anterior cingulate cortex circuit that contributes to affective-attention pain behaviors, and determine its overlap with endogenous mu opioid receptor systems. The grant also...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $118,457 to The Trustees of the University of Pennsylvania to conduct research aimed at elucidating the genetic architecture and underpinnings of chronic pain and identifying potential novel pain medications. The key objectives are to 1) characterize the genetic liability for chronic pain and addiction, 2) estimate the causal effects of brain and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), totaling $945,966 over the period of September 30, 2024 to July 31, 2029, will support research to unravel the neurobiological mechanisms by which the neuropeptide PEN and its receptor GPR83 interact with the mu-opioid receptor (MOR) in the periaqueductal gray (PAG) region of the brain. The goal is to determine if targeting the PEN-GPR83 pathway...
This $159,711 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a study titled "Electrophysiological Dynamics of Acute Opioid Use in Human Reward, Affect, and Pain Pathways." The project aims to investigate how acute opioid administration impacts neural connectivity within brain regions associated with opioid use disorder (OUD), including the amygdala, hippocampus, prefrontal cortex, and pain...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders grant program (CFDA 93.853), provides $497,550.00 to The Washington University in St. Louis to conduct research on understanding how endogenous opioid systems regulate the analgesic (pain-relieving) properties of the locus coeruleus noradrenergic system. The research aims to elucidate the mechanisms by which...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $708,397 to The Research Foundation For The State University Of New York, doing business as Stony Brook University, to investigate the role of inflammasomes in the development of opioid-induced hyperalgesia (OIH) in the context of HIV-associated pain. The key objectives of this 5-year research project are to: 1) construct a cell atlas of...
This $2,103,564 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the cellular mechanisms and therapeutic potential of the nuclear receptor NR4A1 in pain resolution. The grant will fund research to test whether NR4A1 in macrophages controls the resolution of inflammation and postoperative pain, whether NR4A1 agonists can promote pain resolution, and whether NR4A1...
The federal Project Grant award, titled "INVESTIGATING THE ROLE OF DORSAL RAPHE NUCLEUS ENKEPHALIN NEURONS IN MOTIVATIONAL AND AFFECTIVE BEHAVIORS DURING CHRONIC PAIN," is funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The primary goal of this $154,568 F32 award, with a performance period from June 12, 2025 to December 31, 2028, is to determine the contribution of endogenous opioids within the dorsal raphe nucleus...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded $858,000 under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to Western University of Health Sciences from June 2022 through May 2025. The Project Grant will support research examining pain-induced impulsivity in rats and its underlying mechanisms. Specifically, the awardee will introduce a rodent model of the cognitive component of pain using a delay discounting...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,068,842 to Trustees of Indiana University (Indianapolis) to conduct research on the role of prefrontal cortical dynorphin circuits in modulating pain states and associated maladaptive behaviors. The 3-year grant, awarded on September 20, 2024, aims to use ex-vivo electrophysiology and in-vivo calcium imaging...